12/9
08:30 am
achv
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
Low
Report
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
12/3
08:44 am
achv
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA [Yahoo! Finance]
Medium
Report
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA [Yahoo! Finance]
12/3
08:30 am
achv
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA
Low
Report
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA
11/25
08:02 am
achv
Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma) [Yahoo! Finance]
Medium
Report
Smoking Cessation Pipeline Insight 2024, with Focus on Emerging Drugs Cytisinicline (Achieve Life Sciences), EMB-001(Embera Pharmaceuticals) and SBP-9330 (Camino Pharma) [Yahoo! Finance]
11/15
05:59 am
achv
Achieve Life Sciences, Inc. (NASDAQ: ACHV) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Medium
Report
Achieve Life Sciences, Inc. (NASDAQ: ACHV) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
11/14
08:42 am
achv
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences [Yahoo! Finance]
11/14
08:30 am
achv
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Medium
Report
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
11/14
07:21 am
achv
Achieve Life Sciences, Inc. (NASDAQ: ACHV) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $12.00 price target on the stock.
Medium
Report
Achieve Life Sciences, Inc. (NASDAQ: ACHV) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $12.00 price target on the stock.
11/8
02:18 pm
achv
Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Low
Report
Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
11/7
04:05 pm
achv
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
Medium
Report
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
10/24
08:00 am
achv
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024
Medium
Report
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024
10/23
08:05 am
achv
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting [Financial Post (Toronto, Ontario, Canada)]
10/23
08:00 am
achv
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting
Medium
Report
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting
10/16
08:00 am
achv
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline
Low
Report
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline
10/10
08:00 am
achv
Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting
Medium
Report
Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting
10/1
08:59 am
achv
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs [Yahoo! Finance]
Medium
Report
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs [Yahoo! Finance]
10/1
08:45 am
achv
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs
Medium
Report
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs
9/27
07:41 am
achv
Achieve Life Sciences, Inc. (NASDAQ: ACHV) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $20.00 price target on the stock.
Medium
Report
Achieve Life Sciences, Inc. (NASDAQ: ACHV) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $20.00 price target on the stock.